Another study by Xia et al. found that IGF2 mRNA was markedly reduced in AD patients and when they treated Tg2576 AD model mice with IGF2 they improved memory consolidation, decreased Aβ deposition and reduced oxidative stress through the activation of the PI3K/AKT pathway [53]. The gene discussed is AKT1; the disease is Alzheimer disease.